On May 28, MicroPort Scientific fell 5.12% in regular trading, trading at HKD 7.42/share, with trading volume of HKD 78.60 million.

On the news front, Morgan Stanley recently issued a research report cutting MicroPort Scientific's target price from HKD 16 to HKD 10.5, while raising the holding company discount from 30% to 45%, citing liquidity slowdown and subdued industry sentiment. The bank noted that management guided only low single-digit revenue growth for the first half, and that Middle East conflict has disrupted overseas delivery of interventional and orthopedic products. The company reiterated its full-year high single-digit growth target.

Meanwhile, the broader Health Care Equipment sector came under selling pressure, with MEDBOT-B down 4.36%, AK Medical down 4.29%, Lifetech Scientific down 3.87%, and Angelalign down 2.56%, amplifying sector-wide weakness and intensifying the decline in individual stocks.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)